Tartalomhoz ugrás
Vissza a kereséshez
Ez az ajánlat visszavonva lett.

Belgium – Általános fertőzésellenes szerek szisztémás használatra, vakcinák, daganatellenes és immunmodulátor szerek – Raamovereenkomst voor de aankoop van anti-infectieuze middelen

AZ St.-Elisabeth Herentals vzwBelgiumMegjelent 2026. júl. 14.
Határidő lejárt

Leírás

RAAMOVEREENKOMST VOOR DE AANKOOP VAN ANTI-INFECTIEUZE MIDDELEN

ANTI-INFECTIÓS SZEREK VÉTÉLÉHEZ SZOLGÁLTATÁSOKRA VONATKOZÓ RÁMÉRENKÖZMEGYEZÉS

TED NOTICE NUMBER: 2023/S 111-294663

Contract notice

Section I: Contracting authority

I.1) Name and addresses

Official name: European Commission

Postal address: Rue de la Loi 170, 1049 Brussels

Country: Belgium

E-mail: [email address]

I.2) Joint procurement

The contract involves joint procurement

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: https://etendering.ec.europa.eu

Additional information can be obtained from the abovementioned address

Tenders or requests to participate must be submitted electronically via: https://etendering.ec.europa.eu

I.4) Type of the contracting authority

European institution/agency

I.5) Main activity

Health

I.6) Main contact point(s)

For further information, please contact:

European Commission

Procurement Team

Rue de la Loi 170, 1049 Brussels

Country: Belgium

E-mail: [email address]

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Anti-infective products

II.1.2) Main CPV code

33100000

II.1.3) Type of contract

Supplies

II.1.4) Short description

The European Commission intends to conclude a framework agreement for the supply of anti-infective products, including but not limited to: antibiotics, antivirals, antifungals, and antiparasitics.

II.1.5) Estimated total value

Value excluding VAT: 300.000.000,00 EUR

II.1.6) Information about lots

This contract is divided into lots: yes

II.2) Description

II.2.1) Title

II.2.2) Additional description

The framework agreement will cover a wide range of anti-infective products, including but not limited to: antibiotics, antivirals, antifungals, and antiparasitics. The products must comply with the relevant EU regulations and standards.

II.2.3) Common procurement vocabulary (CPV) codes

33100000

II.2.4) Quantity or scope

The estimated total value of the framework agreement is 300.000.000,00 EUR (excluding VAT). The framework agreement will have a duration of 48 months, with the possibility of extension for an additional 24 months.

II.2.5) Renewal

This is a recurrent procurement: no

II.2.6) Information about a framework agreement

The procurement involves the establishment of a framework agreement

II.2.7) Information about electronic catalogues

II.2.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes

II.2.9) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.10) Additional information

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2) Economic and financial standing

III.1.3) Technical and professional ability

III.2) Conditions related to the contract

III.2.1) Information about a particular profession

III.2.2) Contract performance conditions

III.2.3) Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.2) Limitations on the number of operators who may participate in the procurement procedure

IV.1.3) Information about a dynamic purchasing system

IV.1.4) Information about electronic auction

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 2023.09.01

Local time: 12:00

IV.3) Award criteria

IV.3.1) Award criteria

The most economically advantageous tender will be evaluated on the basis of the criteria stated below

IV.3.2) Information about electronic auction

Section V: Award of contract

V.1) Award of contract

V.1.1) Information about the successful tenderer

V.1.2) Information about the contract

V.1.3) Information about the value of the contract

V.1.4) Information about subcontracting

V.2) Information about the contract

Section VI: Complementary information

VI.1) Information about the European Union funds

VI.2) Additional information

VI.3) Information about the review procedure

VI.4) Information about the date of dispatch of this notice

VI.5) Information about the date of dispatch of the contract notice

VI.6) Information about the date of dispatch of the contract award notice

VI.7) Information about the date of dispatch of the contract award notice

VI.8) Information about the date of dispatch of the contract award notice

VI.9) Information about the date of dispatch of the contract award notice

VI.10) Information about the date of dispatch of the contract award notice

VI.11) Information about the date of dispatch of the contract award notice

VI.12) Information about the date of dispatch of the contract award notice

VI.13) Information about the date of dispatch of the contract award notice

VI.14) Information about the date of dispatch of the contract award notice

VI.15) Information about the date of dispatch of the contract award notice

CPV kódok

General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents

Dokumentumok és benyújtás

AI összefoglaló
Jelentkezzen be egy AI összefoglalóhoz

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Kapcsolódó közbeszerzések